about
Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activationRole of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationCXCR2: a target for pancreatic cancer treatment?Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic eraTargeting CXCR1/CXCR2 receptor antagonism in malignant melanomaAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisOverexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer.Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1.The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancerRole of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionTNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/EGFR-dependent mechanismTargeting IL-8 in colorectal cancer.CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapySmall molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesisCXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer GrowthCT perfusion can predict overexpression of CXCL8 (interleukin-8) in head and neck squamous cell carcinoma.Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancerCXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis.Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexesEnhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilsiRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice.Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway.CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.The Role of PPARs in the Endothelium: Implications for Cancer Therapy
P2860
Q24298015-CD48A526-D49D-44D8-9E04-E6E03DB73827Q26796395-7C73E2EC-B809-4F2C-9FFD-51B6F432AA5AQ27021588-FAC58C27-A34C-488E-A092-10B1CFE8C717Q27024966-53FFAB59-1C1B-4E24-B18C-F1999078BB47Q28276026-9AB1B006-6E37-47F3-8BB3-C626FFEA0CFDQ28397726-16BCF591-6E4E-4275-B12E-D61C38D6C375Q30427989-53F8A496-74C1-4BEB-BB90-96D9A271BFEFQ30437958-B2622001-6065-4299-B786-582CA4EC7B50Q33466073-B5F2C0A7-7392-4A5F-8A0C-E752173CED95Q33514953-C2B3C752-10B7-4968-88AF-FCBFE9D0844FQ33562564-4D19AAE1-20C0-4598-A9C4-FECA10EC2EACQ33625023-80386499-F6A7-41A0-A99A-DFE653C131C3Q33642464-26859099-969A-48D0-937A-4FABD4384984Q33915672-4FF4C426-C74C-4D24-8842-A644705D9CF6Q34090617-909EAB9A-EE64-45E4-A98A-239799B40908Q34155350-1A4E824C-DE0E-43AC-956C-2DC53C6537DEQ34213977-14A3A2C7-8D08-42D9-A17A-A7553A2C1006Q34267408-07E93E05-851B-4F4C-A92E-5565B5742CFFQ34363535-45415ECA-4C6E-4254-828A-6C7BD310A8D9Q34367591-59C4B869-2681-47D9-9990-501CEAC6C4DDQ34512415-F4E7833F-23E9-4C6B-8607-9C3AAC70BFB7Q34518337-50ED62B3-914D-4C03-B2F7-4CD8C368A22CQ34729776-314E8299-4149-4757-96E4-DC47541B67CAQ34734529-C2AE1875-F58A-43F1-BC88-A6F8C613B6E9Q35549511-49D9D54B-BD6F-445C-8C26-D156C4F61056Q35770942-B5990713-0D56-424B-99DA-486BB2BC2CC0Q35791353-32C5710F-8855-4017-B08B-2F143FD8EF3BQ35801350-228A0D01-0D10-47C9-A872-1C14BBFD8F98Q36016645-3568D141-5352-4058-948A-03BF4EBABDA4Q36291113-CA513624-92FD-40F7-8C7F-FF5886F3D829Q36649559-FA1EBB52-5015-4708-BB91-587728AD5241Q36740927-4DEA3077-5E06-4B14-92F3-DE3F4C8EB0EAQ36977544-EC87CB51-785A-4CC1-A438-CE73881BFDE0Q37117592-EDB6D341-4A80-4E8B-8090-B2CB2BE87412Q37124747-993803C0-2B99-48F8-9808-30AF5B1AD0E1Q37189951-E5727EBA-C1AF-4D7A-A445-BF9D16C00BABQ37288883-C839FD69-351D-4274-8C7C-E6A06D1D1BBCQ37291172-AD157717-E392-483B-9883-055BEFE3229DQ37312692-DEA13CA0-5CEC-454A-8138-C4ADCFBCDA37Q37337997-0222F195-C83A-4CAA-A7B7-F0FF97A847FF
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chemokines in tumor angiogenesis and metastasis
@ast
Chemokines in tumor angiogenesis and metastasis
@en
Chemokines in tumor angiogenesis and metastasis
@nl
type
label
Chemokines in tumor angiogenesis and metastasis
@ast
Chemokines in tumor angiogenesis and metastasis
@en
Chemokines in tumor angiogenesis and metastasis
@nl
prefLabel
Chemokines in tumor angiogenesis and metastasis
@ast
Chemokines in tumor angiogenesis and metastasis
@en
Chemokines in tumor angiogenesis and metastasis
@nl
P2860
P1476
Chemokines in tumor angiogenesis and metastasis
@en
P2093
Rakesh K Singh
Seema Singh
P2860
P2888
P304
P356
10.1007/S10555-007-9068-9
P577
2007-12-01T00:00:00Z
P5875
P6179
1015846766